CoRE Signature Highlights
BIOPHARMA DAY

Navigating the Regulatory Frontier

The healthcare landscape is shifting rapidly, and therapeutic product regulation must keep pace. BioPharma Day 2026 brings together regulators, industry leaders, and ecosystem partners to examine what this means in practice — from how the industry development arm will drive Singapore’s strategic growth, to emerging topics such as electronic Product Information (ePI) and the application of artificial intelligence in regulatory affairs. The sessions are designed to foster meaningful collaboration between regulators and industry, equipping participants with practical insights and forward-looking perspectives to navigate the regulatory environment and support timely patient access to safe and effective therapeutic products.

Registration Button

Registration does not guarantee a place at the conference. In the event of oversubscription, places will be allocated by ballot. All registrants will be notified of the outcome via email by 25 September 2026. The organiser's decision is final.

Programme

Programme is tentative and subject to changes.

Joint Opening Session

9.30am

Opening address by Guest-of-Honour

Mr Ong Ye Kung

Minister for Health and Coordinating Minister for Social Policies

9.45am

Keynote by CEO, HSA

Adj Prof (Dr) Raymond Chua

Chief Executive Officer, Health Sciences Authority

10.00am

Panel Discussion 1

Panelists

tbc

Moderator

Adj Prof (Dr) Raymond Chua

10.30am

Tea Break

10.50am

Plenary by Professor John Lim

Prof John Lim

Executive Director, Centre of Regulatory Excellence

11.10am

Panel Discussion 2

Panelists

tbc

Moderator

Prof John Lim

11.50am

Lunch

Joint Fireside Chat Between Biopharma and Medtech Segment

1.30pm

Inside Track: How the Industry Development Arm will catalyse Singapore's strategic pathway from pilot to impact

Panelists

Adj Prof (Dr) Raymond Chua, Mr Eugene Yoo, Ms Poh Hwee Tee (other panelists to be confirmed)

Moderator

Ms Kandyce Ong
Government Affairs Lead, AstraZeneca

2.30pm

Coffee break

Biopharma Day Specific Program

3.00pm

Welcome Remarks by SAPI

3.10pm

Advancing ePI in Singapore: Global ePI developments, Singapore updates and SAPI pilot learning

Speaker 1

Ms Cindy Zen
SAPI RPO & E-labelling WG Lead, Boehringer Ingelheim Singapore Pte. Ltd.

Speaker 2

Ms Phoebe Chan
SAPI RPO & E-labelling WG member, Roche Singapore Pte. Ltd.

3.40pm

Transforming Regulatory Report Development Through AI: An AstraZeneca-HSA Co-Creation Pilot

Speaker

Mr Lim Zhihao
SAPI RAC member, Astra Zeneca Singapore Pte. Ltd.

4.00pm

AI-driven adverse drug reaction surveillance with electronic health records

Speaker

Dr Sreemanee Dorajoo
Senior Data Analyst, HSA

4.20pm

Break

4.40pm

Clinical Trial Site Preparedness: Bridging Operational Excellence and Regulatory Expectations

Speaker

Ms Luisi Khalil
SAPI CTWG, MSD Pharma (Singapore) Pte. Ltd.

5.00pm

Overview of clinical trials landscape

Speaker

tbc

5.20pm

Panel Discussion

Moderator

Mr Wong Kum Cheun
SAPI RAC Co-lead, Novartis Asia Pacific Pharmaceuticals Pte. Ltd.

Panelists

All speakers

6.00pm

End

Navigating the Regulatory Frontier

Browser not supported

Modern websites need modern browsers